REGULATORY & POLICY
Applying RWE to Regulatory Applications
Guests from:
FDA, Janssen, Pfizer, Roche
Includes:
Session details
Q&A session
Transcript
Join our ongoing series of virtual presentations and discussions exploring the principles, practices and possibilities of applying RWE in oncology research.
FDA, Janssen, Pfizer, Roche
Chana Weinstock, MD
FDA
11:00
Kiran Patel, MD
Janssen
14:01
Albert L. Kraus, PhD
Pfizer
12:04
Thibaut Sanglier, PharmD, MPH, PhD
Roche
13:39
Moores Cancer Center, Roche/Genentech, Bristol Myers Squibb, Foundation Medicine
Razelle Kurzrock, MD
Moores Cancer Center
13:33
Michael D. Taylor, PharmD, PhD
Genentech
10:25
Simon Papillon-Cavanagh, PhD
Bristol Myers Squibb
07:10
We're working on scheduling new sessions. Sign up to be notified when new ones are added.
Our monthly email exploring how real-world data is being applied across the oncology drug development lifecycle.
Please enter your work email to receive access to monthly highlights covering newly published scientific literature, best practices and upcoming events featuring Flatiron real-world data.